Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Inflammatory Bowel Disease”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00787202
What this trial is testing

Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis.

Who this might be right for
Ulcerative Colitis
Pfizer 195
Large-scale testing (Phase 3)Looking for participantsNCT07184931
What this trial is testing

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Sanofi 980
Not applicableStudy completedNCT03532932
What this trial is testing

Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life Practice

Who this might be right for
Colitis, UlcerativeCrohn DiseaseInflammatory Bowel Diseases
Takeda 1,990
Large-scale testing (Phase 3)Study completedNCT00552058
What this trial is testing

Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease

Who this might be right for
Crohn Disease
UCB Pharma 439
Post-approval studies (Phase 4)Looking for participantsNCT07663526
What this trial is testing

Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellvi®

Who this might be right for
Crohn's Disease
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 50
Testing effectiveness (Phase 2)Looking for participantsNCT06456593
What this trial is testing

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Who this might be right for
Moderately to Severely Active Crohn Disease
Abivax S.A. 212
Not applicableStudy completedNCT01759264
What this trial is testing

An Observational Study of Fecal Calprotectin as Clinical Tool in Monitoring Moderate-to-severe Crohn's Disease on Adalimumab Induction Therapy: a KoRean Experience (FAIR)

Who this might be right for
Crohn's Disease
AbbVie (prior sponsor, Abbott) 101
Testing effectiveness (Phase 2)Looking for participantsNCT07483073
What this trial is testing

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Who this might be right for
Colitis, UlcerativeCrohn Disease
Eli Lilly and Company 60
Testing effectiveness (Phase 2)Looking for participantsNCT03167437
What this trial is testing

An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab

Who this might be right for
Crohn's Disease
National Institute of Allergy and Infectious Diseases (NIAID) 35
Testing effectiveness (Phase 2)Study completedNCT00267722
What this trial is testing

Visilizumab for Moderate to Severe Inflammatory, Nonstricturing, Nonpenetrating Crohn's Disease

Who this might be right for
Crohn's Disease
Facet Biotech 18
Testing effectiveness (Phase 2)Study completedNCT03368118
What this trial is testing

Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Abivax S.A. 22
Large-scale testing (Phase 3)Study completedNCT03782376
What this trial is testing

Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen-Cilag Ltd. 215
Testing effectiveness (Phase 2)Study completedNCT00603616
What this trial is testing

Induction of Clinical Response Using Rifaximin in Crohn's Disease

Who this might be right for
Crohn's Disease
Scott Lee 36
Large-scale testing (Phase 3)Active Not RecruitingNCT06260163
What this trial is testing

Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 112
Post-approval studies (Phase 4)Study completedNCT03029143
What this trial is testing

Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Takeda 278
Large-scale testing (Phase 3)Study completedNCT00207675
What this trial is testing

The Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's Disease

Who this might be right for
Crohn Disease
Centocor, Inc. 112
Post-approval studies (Phase 4)Looking for participantsNCT06581328
What this trial is testing

Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Who this might be right for
Ulcerative ColitisCrohn's Disease
Takeda 200
Testing effectiveness (Phase 2)Study completedNCT04882007
What this trial is testing

Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
OSE Immunotherapeutics 136
Large-scale testing (Phase 3)Study completedNCT02065622
What this trial is testing

Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
AbbVie 952
Large-scale testing (Phase 3)Study completedNCT00385736
What this trial is testing

Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Abbott 576
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation